Newsfiscal.ai
Neuphoria Therapeutics and Scancell File Registration Statement for Proposed Business Combination
· Published
Article summary
Neuphoria Therapeutics Inc. and Scancell have filed a Registration Statement on Form F-4 with the SEC regarding their proposed business combination.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…